Emergency Department Presentations of Diabetic Ketoacidosis in a Large Cohort of Children

Lise E Nigrovic1, Nathan Kuppermann2,3, Simona Ghetti4

  • 1Division of Emergency Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Pediatric Diabetes
|April 30, 2025
PubMed

Insights

Diabetic ketoacidosis (DKA) in children is influenced by socioeconomic status (SES) and age. Lower SES is linked to more severe DKA, and young children may require closer monitoring for potential cerebral injury.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of childhood diabetes.
  • Demographic factors influencing DKA presentation in children are not well-defined.

Purpose of the Study:

  • To investigate the influence of demographic factors on DKA presentation in children.
  • To compare DKA characteristics across different age groups and diabetes diagnoses.

Main Methods:

  • Analysis of 1,679 DKA episodes in 1,553 children across 12 centers from the PECARN FLUID Trial.
  • Comparison of demographic, clinical, and biochemical data between newly and previously diagnosed diabetes, and across age groups.

Main Results:

  • Nearly half of DKA episodes occurred in newly diagnosed children; 23.6% were severe.
  • Younger children (<6 years) with new-onset DKA showed more severe hypocarbia and higher BUN, associated with cerebral injury risk.
  • Lower socioeconomic status (SES) correlated with more severe DKA in both new-onset and recurrent cases.

Conclusions:

  • Early identification of diabetes and DKA prevention are crucial, especially for low-SES children.
  • Young children with DKA warrant intensive monitoring due to elevated risk of cerebral injury.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
839
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
148
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
136